versions of biologic drugs to come on to the market. The group's members include companies such as Medco Health Solutions Inc. (MHS) and CVS Caremark Corp (CVS). 'Generic competition lowers costs because it gives patients the power to choose and gives...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Specialty Drugs Force High Medicare Out-Of-Pocket Costs
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account